Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoembryonic Antigen”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Early research (Phase 1)Looking for participantsNCT05464030
What this trial is testing

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

Who this might be right for
Colorectal Cancer
EMD Serono Research & Development Institute, Inc. 200
Not applicableStudy completedNCT01980212
What this trial is testing

Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung CancerFirst Line TreatmentThioredoxin Reductase Activity+2 more
Hunan Province Tumor Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00228189
What this trial is testing

Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients

Who this might be right for
Colorectal CancerLiver Metastases
Radboud University Medical Center 30
Early research (Phase 1)Ended earlyNCT00003434
What this trial is testing

Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Duke University 8
Not applicableStudy completedNCT04597814
What this trial is testing

The Relationship Between the Tumor Markers and Interstitial Lung Disease

Who this might be right for
the Relationship Between the Tumor Markers and Interstitial Lung Disease Patients
The First Affiliated Hospital of Guangzhou Medical University 13
Early research (Phase 1)WithdrawnNCT03682744
What this trial is testing

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+4 more
Sorrento Therapeutics, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05071053
What this trial is testing

Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer

Who this might be right for
Adenocarcinoma GastricGastrooesophageal Cancer
Sanofi 35
Testing effectiveness (Phase 2)Study completedNCT00004085
What this trial is testing

Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 15
Testing effectiveness (Phase 2)Looking for participantsNCT04755920
What this trial is testing

SGM-101 in Colorectal Brain Metastases.

Who this might be right for
Rectal NeoplasmsRectum CancerColorectal Neoplasms+10 more
Leiden University Medical Center 10
Testing effectiveness (Phase 2)Ended earlyNCT05245071
What this trial is testing

Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Sanofi 22
Early research (Phase 1)Study completedNCT01284231
What this trial is testing

Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas

Who this might be right for
Gastrointestinal Adenocarcinomas
MedImmune LLC 78
Early research (Phase 1)Study completedNCT02350673
What this trial is testing

Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 70
Early research (Phase 1)Study completedNCT02324257
What this trial is testing

RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 149
Testing effectiveness (Phase 2)Ended earlyNCT04659603
What this trial is testing

Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors

Who this might be right for
Breast Cancer MetastaticPancreatic Carcinoma Metastatic
Sanofi 50
Not applicableStudy completedNCT05646030
What this trial is testing

Feasibility, Reliability, and Satisfaction of CEA Using Home Based (Automated) Capillary Blood Sampling

Who this might be right for
Colorectal Cancer
Erasmus Medical Center 102
Early research (Phase 1)Study completedNCT02416466
What this trial is testing

CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases

Who this might be right for
Liver Metastases
Roger Williams Medical Center 8
Early research (Phase 1)Study completedNCT00217373
What this trial is testing

Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)

Who this might be right for
Adult Solid Neoplasm
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT04826003
What this trial is testing

Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment

Who this might be right for
Metastatic Colorectal Cancer
Hoffmann-La Roche 54
Early research (Phase 1)Looking for participantsNCT06043466
What this trial is testing

A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophagus CancerGastric Cancer+4 more
Chongqing Precision Biotech Co., Ltd 30
Testing effectiveness (Phase 2)Ended earlyNCT00003432
What this trial is testing

Immunotherapy in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Duke University 4
Load More Results